Ikena Oncology, and Inmagene Biopharmaceuticals announced the appointment of Kristin Yarema, Ph.D. as Chief Executive Officer of ImageneBio, of the combined company after the...
Ikena Oncology, Inc, and Inmagene Biopharmaceuticals announced they have entered into a definitive merger agreement. In connection with the merger, Ikena has entered into...
